TABLE 2.
Distribution of Hib RFLP type F2a (n = 37), which accounted for 46% of the Aboriginal isolates
| Geographic location | No. of isolates
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Meningitis
|
Epiglottitis
|
Other
|
Carrier
|
Total
|
||||||
| Non-Aboriginal | Aboriginal | Non-Aboriginal | Aboriginal | Non-Aboriginal | Aboriginal | Non-Aboriginal | Aboriginal | Non-Aboriginal | Aboriginal | |
| Canberra | ||||||||||
| Melbourne | ||||||||||
| Sydney | 1 | 1 | ||||||||
| Perth | 3 | 3 | ||||||||
| Townsville | ||||||||||
| Alice Springs region | 1 | 4 | 14a | 4 | 1 | 22 | ||||
| Bathurst Island | 6 | 6 | ||||||||
| Rural Western Australia | 4 | 4 | ||||||||
| Total | 1 | 11 | 1 | 0 | 0 | 14 | 0 | 10 | 2 | 35 |
a
The isolates were associated with pneumonia (n = 5), acute lower respiratory tract infection (n = 3), gastrointestinal disorders (n = 3), cellulitis (n = 1), bronchiolitis (n = 1), and FTT (n = 1).